Kalaris Therapeutics Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Kalaris Therapeutics stock has a consensus rating of "Buy" and an average price target of $18.75. The average 1-year stock price forecast is 288.20% higher than the current stock price, while the lowest is $7.00 (+44.93%) and the highest is $25 (+417.60%).

Price Target: $18.75 (+288.20%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$18.75	$19.5	$25
Change	+44.93%	+288.20%	+303.73%	+417.60%

Analyst Ratings

The average analyst rating for Kalaris Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	2	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yun Zhong Wedbush	Wedbush	Buy Initiates $17	Buy	Initiates	$17	+251.97%	May 14, 2026
Jonathan Wolleben Citizens	Citizens	Buy Maintains $26 → $25	Buy	Maintains	$26 → $25	+417.60%	May 13, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $14	Buy	Initiates	$14	+189.86%	Apr 16, 2026
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Initiates $19	Strong Buy	Initiates	$19	+293.37%	Dec 23, 2025
Jonathan Wolleben Citizens	Citizens	Buy Initiates $20	Buy	Initiates	$20	+314.08%	Nov 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

13.60M

EPS This Year

-2.24

from -2.85

EPS Next Year

-1.43

from -2.24

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-	13.60M	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.48	-2.42	-51.77	-2.85	-2.24	-1.43	-2.39
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	9	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	84.0M
Avg	n/a	13.6M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.84	0.68
Avg	-2.24	-1.43
Low	-2.51	-2.08

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.